BELITE BIO, INC IPO

Completed

BELITE BIO, INC completed its initial public offering on NASDAQ on April 29, 2022, pricing at $6.00 a share.

Ticker	BLTE
Exchange	NASDAQ
Status	Completed
Listing date	April 29, 2022
Offering price	$6.00
Shares offered	6,000,000
Total raised	$36M

The offering

BELITE BIO, INC sold 6,000,000 shares at $6.00 each on NASDAQ. Multiplied out, that is $36 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $36 million total recorded for the deal.

Company coverage

BELITE BIO, INC — quote, profile and latest news →

Other recent IPOs

First Breach, Inc. · August 12, 2026
Advasa Holdings, Inc. · August 11, 2026
Latigo Biotherapeutics, Inc. · August 4, 2026
BOA Acquisition Corp. II · August 3, 2026
Obsidian Therapeutics, Inc. · August 3, 2026
Attovia Therapeutics, Inc. · July 29, 2026
Game Your Game Inc. · July 27, 2026
Scribe Therapeutics, Inc. · July 21, 2026

Source: SEC EDGAR filings for BELITE BIO, INC. This page is general information, not investment advice.